Share Email Print
cover

Proceedings Paper

Verteporfin Photodynamic therapy with 5 aza-deoxy-cytidine for neo-adjuvant treatment of primary breast cancer: Results of pre-clinical investigations
Author(s): S. M. Banerjee; P. Acedo; S. El Sheikh; A. Meecham; N. R. Williams; G. Gerrard; R. Hamoudi; A. J. MacRobert; M. R. S. Keshtgar
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Primary breast cancer treatment relying on surgery with the use neo-adjuvant therapies has long been established treatment. Side effects from these and varying efficacy has lead to the search for novel therapies that may result in improved results. The use of Photodynamic therapy as a novel neo-adjuvant treatment alone and in combination with agents cytotoxic to breast cancer cells was investigated.

Paper Details

Date Published: 7 August 2019
PDF: 1 pages
Proc. SPIE 11070, 17th International Photodynamic Association World Congress, 1107097 (7 August 2019); doi: 10.1117/12.2525337
Show Author Affiliations
S. M. Banerjee, Royal Free London NHS Foundation Trust (United Kingdom)
Univ. College London (United Kingdom)
P. Acedo, Univ. College London (United Kingdom)
S. El Sheikh, Royal Free London NHS Foundation Trust (United Kingdom)
A. Meecham, Univ. College London (United Kingdom)
N. R. Williams, Univ. College London (United Kingdom)
G. Gerrard, Univ. College London (United Kingdom)
R. Hamoudi, Univ. of Sharjah (United Arab Emirates)
Univ. College London (United Kingdom)
A. J. MacRobert, Univ. College London (United Kingdom)
M. R. S. Keshtgar, Royal Free London NHS Foundation Trust (United Kingdom)
Univ. College London (United Kingdom)


Published in SPIE Proceedings Vol. 11070:
17th International Photodynamic Association World Congress
Tayyaba Hasan, Editor(s)

© SPIE. Terms of Use
Back to Top
PREMIUM CONTENT
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?
close_icon_gray